Mary M Waye

Title: Innovations of Mary M Waye

Introduction

Mary M Waye is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of molecular biology through her innovative methods in DNA manipulation. Her work has implications for genetic research and biotechnology.

Latest Patents

Mary M Waye holds a patent for the "Generation of unidirectional deletion mutants." This novel method allows for the introduction of unidirectional deletions into cloned DNA. The technique utilizes a mixture of oligodeoxynucleotide primers with fixed 5' (or 3') ends that define the deletion endpoint, along with variable 3' (or 5') ends composed of mixtures of all four nucleotides at six positions. The 5' ends of the primers are hybridized to a fixed location on the M13K11RX templates, while the 3' ends hybridize randomly to the DNA being analyzed. This method efficiently generates a nested set of deletion mutants that are useful for dideoxy-sequencing and can create deletion mutants with specific codons at the endpoints.

Career Highlights

Mary M Waye is associated with Kinetic Investments Limited, where she continues to advance her research and development efforts. Her innovative approach to DNA manipulation has positioned her as a key figure in her field.

Collaborations

Mary collaborates with Wenyan Shen, contributing to the advancement of their shared research interests.

Conclusion

Mary M Waye's contributions to the field of molecular biology through her innovative patent demonstrate her expertise and commitment to advancing genetic research. Her work continues to influence the scientific community and pave the way for future innovations.